Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose JOURNAL OF CLINICAL APHERESIS Goodnough, L. T., Kuter, D., McCullough, J., Brecher, M. E. 1998; 13 (3): 114-119


Emerging issues in stimulating apheresis platelet donors with platelet growth factors, the relative costs of apheresis and random donor platelet concentrates, optimal platelet transfusion dose, and leucoreduction of platelet products have caused renewed debate regarding apheresis products vs. random, pooled concentrates. The future role of apheresis products in platelet transfusion therapy will in large part be determined by costs, which are increasingly recognized to be influenced by donor platelet count, apheresis yield, and platelet transfusion dose.

View details for Web of Science ID 000076758800004

View details for PubMedID 9828021